For this study, researchers reviewed cases of 70 patients with recurrent C. difficile who underwent fecal transplantation. Within 12 weeks after transplantation, symptoms subsided in all but four patients with 027 C. difficile infection. These four patients displayed a pre-existing serious condition and subsequently died of colitis.
In addition, four patients had an infectious relapse one year after transplantation, two of whom were treated successfully with another fecal transplantation and two of whom were treated with antibiotics. The researchers did not observe any immediate complications following the transplantations.
Related Articles on Infections:
62 Florida Hospitals Join National Initiative to Improve Safety, Readmissions Rate
IDSA Proposes New Pathway for Antibiotic Approval
Call to Action Aims to Protect Healthcare Workers From Bloodborne Diseases
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
